Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new release of the page content, likely reflecting corrections or updates.
    Difference
    0.0%
    Check dated 2026-05-18T05:57:02.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a non-clinical update to the site release metadata.
    Difference
    0.0%
    Check dated 2026-04-26T15:43:48.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:17:20.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:17:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T05:20:22.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to content or functionality on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:38:40.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.